MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

18.04 -0.82

Resumen

Variación precio

24h

Actual

Mínimo

17.8

Máximo

18.09

Métricas clave

By Trading Economics

Ingresos

67M

-681K

Ventas

-2.9M

17M

P/B

Media del Sector

48.528

88.032

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+13.2% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.26%

Próximas Ganancias

8 ene 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

24M

368M

Apertura anterior

18.86

Cierre anterior

18.04

Noticias sobre sentimiento de mercado

By Acuity

40%

60%

114 / 374 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 ene 2026, 22:45 UTC

Principales Movimientos del Mercado

GH Research Shares Up, Plans to Provide Update on New Drug Application

2 ene 2026, 22:13 UTC

Charlas de Mercado
Ganancias

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2 ene 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

2 ene 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

2 ene 2026, 21:07 UTC

Ganancias

Tesla Stock Pops and Drops After Fourth-Quarter Deliveries. -- Barrons.com

2 ene 2026, 20:09 UTC

Charlas de Mercado

Oil Futures Slip in First Trading Day of the Year -- Market Talk

2 ene 2026, 19:48 UTC

Charlas de Mercado

U.S. Natural Gas Futures Kick Off 2026 With A Loss -- Market Talk

2 ene 2026, 18:53 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

2 ene 2026, 18:53 UTC

Charlas de Mercado

Mexico PMIs Show Manufacturing Weakness in December -- Market Talk

2 ene 2026, 17:56 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Meta's Manus Acquisition May Help Fill AI Monetization Gap -- Market Talk

2 ene 2026, 17:50 UTC

Charlas de Mercado

Apparel Industry Seen With Strength Across Income Levels -- Market Talk

2 ene 2026, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

2 ene 2026, 16:33 UTC

Charlas de Mercado

Remittances to Mexico Fell 5.7% in November -- Market Talk

2 ene 2026, 16:18 UTC

Charlas de Mercado

Tesla Dethroned as World's Largest EV Maker -- Market Talk

2 ene 2026, 15:48 UTC

Ganancias

Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. -- Barrons.com

2 ene 2026, 15:17 UTC

Charlas de Mercado

Tesla Expected to Make Its Switch to Robotics, AI in 2026 -- Market Talk

2 ene 2026, 15:01 UTC

Charlas de Mercado

Sable Seen Nearing Production Relaunch After Court Ruling -- Market Talk

2 ene 2026, 15:00 UTC

Ganancias

The Maker of Biscoff Cookies Bets on a Global Expansion -- WSJ

2 ene 2026, 14:56 UTC

Charlas de Mercado

Tesla's Sales Drop Was Better Than Feared -- Market Talk

2 ene 2026, 14:20 UTC

Charlas de Mercado

Capstone Copper's Mantoverde Strike Could Be Costly -- Market Talk

2 ene 2026, 14:20 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

2 ene 2026, 14:13 UTC

Charlas de Mercado

Oil Futures Open Year Lower on Oversupply Concerns -- Market Talk

2 ene 2026, 13:39 UTC

Charlas de Mercado

U.S. Natural Gas Futures Open Year Lower -- Market Talk

2 ene 2026, 13:01 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Unicredit Could Buy Delfin's BMPS Stake, Launch Full Takeover, Equita Says -- Market Talk

2 ene 2026, 12:45 UTC

Charlas de Mercado

Emerging-Market Dollar Bonds Record Strong Returns in 2025 -- Market Talk

2 ene 2026, 11:48 UTC

Charlas de Mercado

European Gas Climbs as Cold Weather Bites -- Market Talk

2 ene 2026, 11:36 UTC

Charlas de Mercado

Treasury Yields, Dollar Edge Higher as Near-Term Fed Rate Cut Looks Unlikely -- Market Talk

2 ene 2026, 11:30 UTC

Charlas de Mercado

Copper Rally Continues, Spurred by Supply Shocks -- Market Talk

2 ene 2026, 11:29 UTC

Charlas de Mercado

Dollar Rises After Posting Worst Year Since 2017 -- Market Talk

2 ene 2026, 11:15 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

13.2% repunte

Estimación a 12 Meses

Media 20.5 USD  13.2%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

114 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat